{"text": "RT @JNJNews: Join the $JNJ Q1 2020 #earnings call and webcast now: https://t.co/njfghlaKbw https://t.co/2HLRY1dyNd", "id": "1250885962588205063", "created_at": "2020-04-16T20:37:08.000Z", "author_id": "916361655881289728"}
{"author_id": "1201337253659725826", "created_at": "2020-04-16T18:04:13.000Z", "text": "$msft, $aapl, $baba, $fb, $v, $jnj, $wmt, $jpm, $pg, $ma, $tsm, $intc, $vz, $bac, $t, $mrk, $ko, $pfe, $dis, $csco, $nflx, $xom, $nvda, $vcx, $nke, $crm, $bmy, $mdt,  #stocks, $a, $f #trades, #investing, #TradesAfterWork https://t.co/4DOcxa454c", "id": "1250847478171136001"}
{"text": "RT @gualestrit: Johnson &amp; Johnson asegura que tendr\u00e1 entre 600 y 800 millones de vacunas contra el #COVID19 en 2021.\n\n$JNJ\n\nhttps://t.co/qz\u2026", "id": "1250912394760552448", "created_at": "2020-04-16T22:22:10.000Z", "author_id": "223606821"}
{"text": "@MarkC53916729 @DewDiligence A well-designed HBV drug using RNAi as a backbone $JNJ + $ARWR might never need to use pegIFN because results might show endogenous-IFNs (maybe Type-I IFN) being produced at a more natural, non-systemic level than in combo with pegIFN as a drug. $VIR results might not be as good.", "id": "1250749767459594240", "created_at": "2020-04-16T11:35:57.000Z", "author_id": "1191093220811259904"}
{"text": "RT @FishburnSimone: How one of the biggest ever consortium of pharmas is pooling resources, sharing data, to solve #COVID19 by channeling i\u2026", "id": "1250870816604069890", "created_at": "2020-04-16T19:36:57.000Z", "author_id": "19690287"}
